Subscribe to Money Morning get daily headlines subscribe now! Money Morning Private Briefing today's private briefing Access Your Profit Alerts

Wall Street's Suddenly Sniffing Around This "Double Your Money Stock"

Aimmune Therapeutics Inc. (Nasdaq: AIMT) has been all over the place since shares of the Brisbane, Calif.-based food-allergy biotech soared 50% in its initial public offering (IPO) back in early August.

We anticipated the whipsawing, which is why we urged folks to use an "accumulate" strategy - and a time frame of two years or more.

Our view hasn't changed.

And now we have company.

Leave a Reply

Your email address will not be published. Required fields are marked *

Some HTML is OK